RT Journal Article SR Electronic T1 In Vivo Activity of a Phospholipase C Inhibitor, 1-(6-((17β-3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in Acute and Chronic Inflammatory Reactions JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 697 OP 704 DO 10.1124/jpet.103.060574 VO 309 IS 2 A1 Hou, Cuifen A1 Kirchner, Thomas A1 Singer, Monica A1 Matheis, Michele A1 Argentieri, Dennis A1 Cavender, Druie YR 2004 UL http://jpet.aspetjournals.org/content/309/2/697.abstract AB To investigate the role of phospholipase C (PLC) in inflammatory processes, we tested 1-(6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), a widely used PLC inhibitor, in several in vitro and in vivo assays. We first examined the effects of U73122 on human phospholipase C-β (PLC-β) isozymes and found that U73122 significantly inhibited recombinant human PLC-β2, with an IC50 of ∼6 μM. U73122 had little effect on PLC-β1, PLC-β3, or PLC-β4. Consistent with its ability to inhibit PLC-β2 enzymatic activity, U73122 reduced interleukin-8 and leukotriene B4-induced Ca2+ flux and chemotaxis in human neutrophils in a concentration-dependent manner. In vivo, U73122 blocked carrageenan-induced hind paw edema in rats, carrageenan-induced macrophage and lymphocyte accumulation into subcutaneous chambers in dogs, lipopolysaccharide-induced macrophage, lymphocyte infiltration and prostaglandin E2 production in a mouse peritonitis model, and 12-O-tetradecanoylphorbol-13-acetate-induced ear edema in mice. These results implicate PLC-dependent signaling pathways in the development of acute and chronic inflammatory responses in vivo. The American Society for Pharmacology and Experimental Therapeutics